Latest Report on Vectibix (Colorectal Cancer) - Forecast and Market Analysis 2023 Share
GlobalData has released its new PharmaPoint Drug Evaluation report, Vectibix (Colorectal Cancer) - Forecast and Market Analysis to 2023. Colorectal cancer (CRC) is the second leading cause of mortality among cancer patients in the world and is the third most diagnosed cancer globally, and thus represents a huge burden on healthcare systems.
View full press release